Repligen Corp (RGEN)
145.15
+5.13
(+3.66%)
USD |
NASDAQ |
Mar 24, 16:00
144.41
-0.74
(-0.51%)
Pre-Market: 09:10
Repligen Market Cap: 8.150B for March 24, 2025
View 4,000+ Financial Data Types:
Add
Browse
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
908 Devices Inc | 149.80M |
Baxter International Inc | 17.19B |
ICU Medical Inc | 3.673B |
UFP Technologies Inc | 1.617B |
Perspective Therapeutics Inc | 170.32M |
Market Cap Related Metrics
PS Ratio | 12.87 |
Price to Book Value | 4.131 |
Price to Free Cash Flow | 57.31 |
Price | 145.15 |
Earnings Yield | -0.31% |